VIA
Vident Investment Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-15,634
| Closed | -$11.2M | – | 806 |
|
2023
Q2 | $11.2M | Sell |
15,634
-4,650
| -23% | -$3.34M | 0.39% | 60 |
|
2023
Q1 | $16.7M | Buy |
20,284
+1,679
| +9% | +$1.38M | 0.54% | 31 |
|
2022
Q4 | $13.4M | Buy |
18,605
+9,755
| +110% | +$7.04M | 0.51% | 32 |
|
2022
Q3 | $5.79M | Sell |
8,850
-9,897
| -53% | -$6.48M | 0.19% | 147 |
|
2022
Q2 | $11.1M | Buy |
18,747
+9,768
| +109% | +$5.78M | 0.33% | 66 |
|
2022
Q1 | $6.27M | Sell |
8,979
-4,634
| -34% | -$3.24M | 0.16% | 146 |
|
2021
Q4 | $8.6M | Sell |
13,613
-2,355
| -15% | -$1.49M | 0.22% | 89 |
|
2021
Q3 | $9.66M | Buy |
15,968
+3,100
| +24% | +$1.88M | 0.29% | 66 |
|
2021
Q2 | $7.19M | Sell |
12,868
-1,640
| -11% | -$916K | 0.22% | 78 |
|
2021
Q1 | $6.86M | Buy |
14,508
+4,834
| +50% | +$2.29M | 0.23% | 76 |
|
2020
Q4 | $4.67M | Buy |
9,674
+1,419
| +17% | +$685K | 0.19% | 90 |
|
2020
Q3 | $4.62M | Buy |
8,255
+493
| +6% | +$276K | 0.23% | 87 |
|
2020
Q2 | $4.84M | Buy |
7,762
+10
| +0.1% | +$6.24K | 0.25% | 78 |
|
2020
Q1 | $3.79M | Buy |
7,752
+3,276
| +73% | +$1.6M | 0.25% | 77 |
|
2019
Q4 | $1.68M | Sell |
4,476
-443
| -9% | -$166K | 0.1% | 301 |
|
2019
Q3 | $1.36M | Sell |
4,919
-169
| -3% | -$46.9K | 0.12% | 129 |
|
2019
Q2 | $1.59M | Buy |
5,088
+655
| +15% | +$205K | 0.13% | 110 |
|
2019
Q1 | $1.82M | Sell |
4,433
-88
| -2% | -$36.1K | 0.1% | 309 |
|
2018
Q4 | $1.69M | Buy |
4,521
+3,209
| +245% | +$1.2M | 0.09% | 293 |
|
2018
Q3 | $530K | Sell |
1,312
-402
| -23% | -$162K | 0.02% | 670 |
|
2018
Q2 | $591K | Sell |
1,714
-279
| -14% | -$96.2K | 0.02% | 598 |
|
2018
Q1 | $637K | Sell |
1,993
-175
| -8% | -$55.9K | 0.03% | 512 |
|
2017
Q4 | $815K | Buy |
2,168
+1,720
| +384% | +$647K | 0.04% | 412 |
|
2017
Q3 | $200K | Buy |
+448
| New | +$200K | 0.01% | 716 |
|
2015
Q3 | – | Sell |
-10
| Closed | -$5K | – | 1136 |
|
2015
Q2 | $5K | Buy |
+10
| New | +$5K | ﹤0.01% | 1016 |
|